Abstract
Treatment options for schizophrenia include oral antipsychotics (OAs) and long-acting injectable antipsychotics (LAIs). Previous studies have reported that patients taking LAIs have lower relapse/re-hospitalization risks; however, more patients are prescribed OAs than LAIs. Here, we explore differences in re-hospitalization rates after schizophrenia-related hospitalization for patients prescribed LAIs vs OAs at discharge.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have